Cytogenetic alterations in CML: not all created equal

Por Gong, Zimu, Wang, Wei, Hu, Shimin
Publicado no Oncotarget (2018)

Revolutionary changes in salvage treatment for Hodgkin lymphoma: toward a chemotherapy-free future

Por Chen, Jiawen, Yang, Wei, Gong, Zimu
Publicado no Ann Transl Med (2018)

Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature

Por Wang, Xiaotian, Gong, Zimu, Li, Shawn Xiang, Yan, Wei, Song, Yongsheng
Publicado no BMC Urol (2017)

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study

Por Abu-Sbeih, Hamzah, Ali, Faisal S., Alsaadi, Dana, Jennings, Joseph, Luo, Wenyi, Gong, Zimu, Richards, David M., Charabaty, Aline, Wang, Yinghong
Publicado no J Immunother Cancer (2018)

Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy

Por Gong, Zimu, Medeiros, L. Jeffrey, Cortes, Jorge E., Chen, Zi, Zheng, Lan, Li, Yan, Bai, Shi, Lin, Pei, Miranda, Roberto N., Jorgensen, Jeffrey L., McDonnell, Timothy J., Wang, Wei, Kantarjian, Hagop M., Hu, Shimin
Publicado no Blood Adv (2017)